A detailed history of Bank Of Nova Scotia transactions in Moderna, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 31,754 shares of MRNA stock, worth $3.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,754
Previous 45,800 30.67%
Holding current value
$3.77 Million
Previous $4.55 Million 25.71%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $1.2 Million - $1.62 Million
-14,046 Reduced 30.67%
31,754 $3.38 Million
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $1.29 Million - $1.94 Million
18,574 Added 68.22%
45,800 $4.55 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $578,460 - $759,660
6,000 Added 28.27%
27,226 $2.81 Million
Q2 2023

Aug 03, 2023

BUY
$118.5 - $160.53 $1.02 Million - $1.39 Million
8,644 Added 68.7%
21,226 $2.58 Million
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $9.79 Million - $14.2 Million
-72,170 Reduced 85.15%
12,582 $1.93 Million
Q4 2022

Feb 09, 2023

SELL
$118.38 - $210.04 $8.53 Million - $15.1 Million
-72,046 Reduced 45.95%
84,752 $15.2 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $1.59 Million - $2.61 Million
-13,465 Reduced 7.91%
156,798 $18.5 Million
Q2 2022

Aug 08, 2022

BUY
$117.13 - $176.59 $19 Million - $28.6 Million
161,990 Added 1958.06%
170,263 $24.3 Million
Q2 2022

Aug 05, 2022

SELL
$117.13 - $176.59 $21.8 Million - $32.8 Million
-185,958 Reduced 95.74%
8,273 $1.18 Million
Q1 2022

May 09, 2022

SELL
$126.46 - $235.05 $6.16 Million - $11.4 Million
-48,699 Reduced 20.05%
194,231 $33.5 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $30.6 Million - $49.9 Million
135,395 Added 125.91%
242,930 $61.8 Million
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $9.45 Million - $20.6 Million
-42,573 Reduced 28.36%
107,535 $41.4 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $19.5 Million - $35.3 Million
150,108 New
150,108 $35.3 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.